HK Stock MarketDetailed Quotes

01099 SINOPHARM

Watchlist
  • 21.550
  • -0.200-0.92%
Market Closed Apr 26 16:08 CST
67.25BMarket Cap6.73P/E (TTM)

SINOPHARM Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
(Q6)Jun 30, 2021
Cash flow from operating activities
Earning before tax
----
10.77%8.87B
----
9.18%18.56B
----
3.72%8B
----
9.01%17B
----
24.12%7.72B
Profit adjustment
Dividend (income)- adjustment
----
-13.27%-606K
----
59.20%-13.05M
----
-9.41%-535K
----
-735.77%-31.99M
----
66.80%-489K
Attributable subsidiary (profit) loss
----
-16.51%-574.28M
----
0.26%-1.07B
----
-8.35%-492.88M
----
-8.35%-1.07B
----
-23.25%-454.91M
Impairment and provisions:
--0
33.26%1.32B
--0
-40.61%729.81M
--0
36.52%989.38M
--0
5.91%1.23B
--0
-1.80%724.74M
-Other impairments and provisions
----
33.26%1.32B
----
-40.61%729.81M
----
36.52%989.38M
----
5.91%1.23B
----
-1.80%724.74M
Revaluation surplus:
--0
100.98%76K
--0
62.88%-13.18M
--0
-27,560.71%-7.75M
--0
27.78%-35.52M
--0
97.14%-28K
-Other fair value changes
----
100.98%76K
----
62.88%-13.18M
----
-27,560.71%-7.75M
----
27.78%-35.52M
----
97.14%-28K
Asset sale loss (gain):
--0
-624.34%-145.17M
--0
93.10%1.73B
--0
64.05%-20.04M
--0
-9.04%896.77M
--0
-29.85%-55.75M
-Loss (gain) from sale of subsidiary company
----
32.50%-5.01M
----
2,559.50%36.38M
----
36.58%-7.42M
----
98.70%-1.48M
----
39.79%-11.7M
-Loss (gain) on sale of property, machinery and equipment
----
-1,804.81%-89.89M
----
-907.43%-17.22M
----
88.30%-4.72M
----
92.95%-1.71M
----
-1,020.28%-40.32M
-Loss (gain) from selling other assets
----
-536.22%-50.27M
----
90.28%1.71B
----
-111.94%-7.9M
----
-19.91%899.96M
----
81.27%-3.73M
Depreciation and amortization:
--0
4.95%2.1B
--0
6.19%4.17B
--0
6.31%2B
--0
9.03%3.92B
--0
18.27%1.88B
-Depreciation
----
1.40%1.85B
----
6.61%3.77B
----
6.62%1.82B
----
10.39%3.54B
----
20.32%1.71B
-Amortization of intangible assets
----
41.25%252.29M
----
2.35%390.66M
----
3.26%178.62M
----
-2.14%381.67M
----
1.19%172.98M
Financial expense
----
-8.05%1.62B
----
-6.16%3.44B
----
0.73%1.76B
----
10.44%3.66B
----
5.60%1.75B
Special items
----
-25.84%258.48M
----
-5.33%-97.81M
----
22.59%348.52M
----
-35.07%-92.86M
----
-19.35%284.29M
Operating profit before the change of operating capital
--0
6.84%13.44B
--0
7.66%27.44B
--0
6.22%12.58B
--0
8.30%25.48B
--0
16.83%11.84B
Change of operating capital
Inventory (increase) decrease
----
-9.67%-6.09B
----
-118.72%-9.5B
----
-50.80%-5.55B
----
-18.23%-4.35B
----
6.12%-3.68B
Accounts receivable (increase)decrease
----
-78.80%-71.58B
----
103.86%1.01B
----
11.66%-40.04B
----
-17.79%-26.23B
----
-35.38%-45.32B
Accounts payable increase (decrease)
----
691.93%24B
----
-50.70%9.91B
----
-76.50%3.03B
----
24.56%20.1B
----
2,099.92%12.89B
prepayments (increase)decrease
----
141.16%933.46M
----
-6,060.39%-7.5B
----
-528.53%-2.27B
----
117.91%125.9M
----
-388.21%-360.86M
Cash  from business operations
--0
-27.76%-40.76B
--0
89.53%25.36B
--0
-24.49%-31.9B
--0
-9.64%13.38B
--0
0.75%-25.63B
Other taxs
----
-7.46%-2.57B
----
-7.98%-4.4B
----
-11.64%-2.39B
----
-11.45%-4.07B
----
-20.62%-2.14B
Special items of business
----
-528.35%-1.46B
----
328.63%4.01B
----
134.03%340.9M
----
-198.28%-1.76B
----
-151.11%-1B
Net cash from operations
-26.22%-39.67B
-26.34%-43.33B
-11.51%-40.69B
125.22%20.96B
-2.62%-31.43B
-23.50%-34.29B
-4.74%-36.49B
-16.55%9.31B
-16.60%-30.63B
-0.62%-27.77B
Cash flow from investment activities
Interest received - investment
----
-2.94%38.67M
----
-11.99%74.56M
----
-11.41%39.84M
----
-7.44%84.71M
----
2.06%44.97M
Dividend received - investment
----
-40.13%59.85M
----
29.62%565.09M
----
76.25%99.97M
----
3.98%435.98M
----
-58.99%56.72M
Restricted cash (increase) decrease
----
54.58%1.76B
----
-415.16%-1.76B
----
22.01%1.14B
----
-68.68%559.74M
----
-69.74%935.43M
Sale of fixed assets
1,127.92%347.35M
20.02%50.09M
-12.59%5.49M
28.60%172.34M
90.67%28.29M
-23.82%41.74M
187.84%6.27M
-22.76%134.01M
-36.18%14.84M
-33.62%54.79M
Purchase of fixed assets
8.18%-1.35B
17.32%-719.37M
5.02%-406.41M
-2.57%-2.13B
-8.98%-1.47B
-9.86%-870.08M
-14.21%-427.89M
-9.30%-2.07B
-20.34%-1.35B
-34.46%-791.96M
Selling intangible assets
----
148.54%23.33M
----
-87.90%4.58M
----
61.43%9.39M
----
394.47%37.83M
----
19.45%5.82M
Purchase of intangible assets
----
-161.26%-137.47M
----
-59.79%-290.39M
----
13.68%-52.62M
----
4.30%-181.73M
----
23.82%-60.96M
Sale of subsidiaries
----
324.06%44.19M
----
533.76%117.26M
----
-51.10%10.42M
----
-93.40%18.5M
----
-80.01%21.31M
Acquisition of subsidiaries
28.05%-74.4M
78.27%-36.47M
---26.14M
10.44%-453.97M
50.35%-103.4M
28.68%-167.82M
----
81.28%-506.86M
91.47%-208.26M
62.12%-235.3M
Recovery of cash from investments
122.57%32.05M
-32.50%93.81M
--12.52M
-29.22%212.16M
-92.69%14.4M
141.73%138.98M
----
268.95%299.76M
105.59%197.03M
142.81%57.49M
Cash on investment
49.25%-90.57M
----
-62.76%-46.17M
-33.33%-100M
68.59%-178.46M
---66K
2.45%-28.37M
-87.38%-75M
-440.10%-568.11M
----
Other items in the investment business
65.13%1.15B
---326K
64.54%876.73M
----
-66.03%696.65M
----
-44.66%532.85M
----
-30.35%2.05B
----
Net cash from investment operations
101.27%12.85M
201.89%1.18B
402.02%416.01M
-183.33%-3.59B
-849.60%-1.01B
342.82%391.03M
-78.32%82.87M
42.48%-1.27B
122.31%135.4M
-95.56%88.3M
Net cash before financing
-22.24%-39.66B
-24.32%-42.15B
-10.62%-40.28B
116.07%17.37B
-6.40%-32.44B
-22.48%-33.9B
-5.66%-36.41B
-10.17%8.04B
-13.46%-30.49B
-8.10%-27.68B
Cash flow from financing activities
New borrowing
7.23%97.25B
13.87%62.01B
27.18%37.09B
12.97%89.16B
5.51%90.69B
9.94%54.45B
-25.76%29.16B
0.93%78.92B
2.68%85.96B
-6.35%49.53B
Refund
1.10%-69.57B
-6.61%-34.94B
-50.20%-21.43B
-4.74%-84.7B
5.32%-70.34B
11.24%-32.77B
51.34%-14.27B
-22.85%-80.87B
-29.52%-74.3B
-7.10%-36.92B
Issuance of bonds
----
7.94%6.8B
----
-17.67%17.29B
----
-56.54%6.3B
----
-21.28%21B
----
-6.58%14.49B
Interest paid - financing
----
23.17%-1.42B
----
-4.43%-4.78B
----
5.75%-1.85B
----
1.48%-4.58B
----
11.06%-1.96B
Dividends paid - financing
-12.67%-7.52B
-39.57%-1.13B
-14.36%-1.17B
-3.94%-4.01B
-3.04%-6.67B
22.20%-809.18M
1.91%-1.02B
-5.51%-3.86B
-5.81%-6.48B
-7.62%-1.04B
Absorb investment income
-48.51%94.42M
-76.43%34.6M
-78.49%13.9M
-57.14%217.81M
-56.51%183.36M
-38.69%146.78M
-40.86%64.63M
-28.85%508.15M
-89.78%421.64M
17.44%239.39M
Issuance expenses and redemption of securities expenses
----
-350.00%-9B
----
28.68%-17B
----
82.67%-2B
----
23.12%-23.84B
----
-44.25%-11.54B
Other items of the financing business
-166.71%-2.57B
-10.54%-1.06B
14.14%6.61B
5.73%-1.87B
922.68%3.85B
-1.83%-956.08M
34.05%5.79B
0.24%-1.98B
90.49%-468.39M
-19.03%-938.9M
Adjustment item of financing business
----
----
----
----
----
----
----
----
---0.01
----
Net cash from financing operations
-0.16%17.69B
-5.41%21.3B
7.03%21.11B
61.25%-5.69B
244.48%17.71B
89.82%22.51B
47.85%19.72B
-825.27%-14.69B
-73.54%5.14B
-53.92%11.86B
Effect of rate
-67.16%9.25M
0.76%5.46M
-269.17%-5.1M
277.81%11.51M
1,140.96%28.17M
393.98%5.42M
-200.95%-1.38M
-64.54%3.05M
-106.21%-2.71M
133.61%1.1M
Net Cash
-49.40%-21.96B
-83.07%-20.85B
-14.89%-19.17B
275.60%11.68B
42.02%-14.7B
28.01%-11.39B
20.99%-16.69B
-160.59%-6.65B
-242.97%-25.35B
-11,847.56%-15.82B
Begining period cash
26.86%55.22B
26.86%55.22B
27.68%55.7B
-13.25%43.53B
-13.25%43.53B
-13.25%43.53B
-13.24%43.62B
28.03%50.18B
28.03%50.18B
28.03%50.18B
Cash at the end
15.37%33.26B
6.94%34.38B
35.61%36.53B
26.86%55.22B
16.12%28.83B
-6.44%32.15B
-7.64%26.94B
-13.25%43.53B
-21.93%24.83B
-12.62%34.36B
Cash balance analysis
Cash and cash equivalent balance
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
HKAS
CAS (2007)
HKAS
CAS (2007)
HKAS
CAS (2007)
HKAS
CAS (2007)
HKAS
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
Auditor
--
--
--
Ernst & Young Huaming (Special General Partnership), Ernst & Young
--
--
--
Ernst & Young Huaming (Special General Partnership), Ernst & Young
--
--
(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021(Q6)Jun 30, 2021
Cash flow from operating activities
Earning before tax ----10.77%8.87B----9.18%18.56B----3.72%8B----9.01%17B----24.12%7.72B
Profit adjustment
Dividend (income)- adjustment -----13.27%-606K----59.20%-13.05M-----9.41%-535K-----735.77%-31.99M----66.80%-489K
Attributable subsidiary (profit) loss -----16.51%-574.28M----0.26%-1.07B-----8.35%-492.88M-----8.35%-1.07B-----23.25%-454.91M
Impairment and provisions: --033.26%1.32B--0-40.61%729.81M--036.52%989.38M--05.91%1.23B--0-1.80%724.74M
-Other impairments and provisions ----33.26%1.32B-----40.61%729.81M----36.52%989.38M----5.91%1.23B-----1.80%724.74M
Revaluation surplus: --0100.98%76K--062.88%-13.18M--0-27,560.71%-7.75M--027.78%-35.52M--097.14%-28K
-Other fair value changes ----100.98%76K----62.88%-13.18M-----27,560.71%-7.75M----27.78%-35.52M----97.14%-28K
Asset sale loss (gain): --0-624.34%-145.17M--093.10%1.73B--064.05%-20.04M--0-9.04%896.77M--0-29.85%-55.75M
-Loss (gain) from sale of subsidiary company ----32.50%-5.01M----2,559.50%36.38M----36.58%-7.42M----98.70%-1.48M----39.79%-11.7M
-Loss (gain) on sale of property, machinery and equipment -----1,804.81%-89.89M-----907.43%-17.22M----88.30%-4.72M----92.95%-1.71M-----1,020.28%-40.32M
-Loss (gain) from selling other assets -----536.22%-50.27M----90.28%1.71B-----111.94%-7.9M-----19.91%899.96M----81.27%-3.73M
Depreciation and amortization: --04.95%2.1B--06.19%4.17B--06.31%2B--09.03%3.92B--018.27%1.88B
-Depreciation ----1.40%1.85B----6.61%3.77B----6.62%1.82B----10.39%3.54B----20.32%1.71B
-Amortization of intangible assets ----41.25%252.29M----2.35%390.66M----3.26%178.62M-----2.14%381.67M----1.19%172.98M
Financial expense -----8.05%1.62B-----6.16%3.44B----0.73%1.76B----10.44%3.66B----5.60%1.75B
Special items -----25.84%258.48M-----5.33%-97.81M----22.59%348.52M-----35.07%-92.86M-----19.35%284.29M
Operating profit before the change of operating capital --06.84%13.44B--07.66%27.44B--06.22%12.58B--08.30%25.48B--016.83%11.84B
Change of operating capital
Inventory (increase) decrease -----9.67%-6.09B-----118.72%-9.5B-----50.80%-5.55B-----18.23%-4.35B----6.12%-3.68B
Accounts receivable (increase)decrease -----78.80%-71.58B----103.86%1.01B----11.66%-40.04B-----17.79%-26.23B-----35.38%-45.32B
Accounts payable increase (decrease) ----691.93%24B-----50.70%9.91B-----76.50%3.03B----24.56%20.1B----2,099.92%12.89B
prepayments (increase)decrease ----141.16%933.46M-----6,060.39%-7.5B-----528.53%-2.27B----117.91%125.9M-----388.21%-360.86M
Cash  from business operations --0-27.76%-40.76B--089.53%25.36B--0-24.49%-31.9B--0-9.64%13.38B--00.75%-25.63B
Other taxs -----7.46%-2.57B-----7.98%-4.4B-----11.64%-2.39B-----11.45%-4.07B-----20.62%-2.14B
Special items of business -----528.35%-1.46B----328.63%4.01B----134.03%340.9M-----198.28%-1.76B-----151.11%-1B
Net cash from operations -26.22%-39.67B-26.34%-43.33B-11.51%-40.69B125.22%20.96B-2.62%-31.43B-23.50%-34.29B-4.74%-36.49B-16.55%9.31B-16.60%-30.63B-0.62%-27.77B
Cash flow from investment activities
Interest received - investment -----2.94%38.67M-----11.99%74.56M-----11.41%39.84M-----7.44%84.71M----2.06%44.97M
Dividend received - investment -----40.13%59.85M----29.62%565.09M----76.25%99.97M----3.98%435.98M-----58.99%56.72M
Restricted cash (increase) decrease ----54.58%1.76B-----415.16%-1.76B----22.01%1.14B-----68.68%559.74M-----69.74%935.43M
Sale of fixed assets 1,127.92%347.35M20.02%50.09M-12.59%5.49M28.60%172.34M90.67%28.29M-23.82%41.74M187.84%6.27M-22.76%134.01M-36.18%14.84M-33.62%54.79M
Purchase of fixed assets 8.18%-1.35B17.32%-719.37M5.02%-406.41M-2.57%-2.13B-8.98%-1.47B-9.86%-870.08M-14.21%-427.89M-9.30%-2.07B-20.34%-1.35B-34.46%-791.96M
Selling intangible assets ----148.54%23.33M-----87.90%4.58M----61.43%9.39M----394.47%37.83M----19.45%5.82M
Purchase of intangible assets -----161.26%-137.47M-----59.79%-290.39M----13.68%-52.62M----4.30%-181.73M----23.82%-60.96M
Sale of subsidiaries ----324.06%44.19M----533.76%117.26M-----51.10%10.42M-----93.40%18.5M-----80.01%21.31M
Acquisition of subsidiaries 28.05%-74.4M78.27%-36.47M---26.14M10.44%-453.97M50.35%-103.4M28.68%-167.82M----81.28%-506.86M91.47%-208.26M62.12%-235.3M
Recovery of cash from investments 122.57%32.05M-32.50%93.81M--12.52M-29.22%212.16M-92.69%14.4M141.73%138.98M----268.95%299.76M105.59%197.03M142.81%57.49M
Cash on investment 49.25%-90.57M-----62.76%-46.17M-33.33%-100M68.59%-178.46M---66K2.45%-28.37M-87.38%-75M-440.10%-568.11M----
Other items in the investment business 65.13%1.15B---326K64.54%876.73M-----66.03%696.65M-----44.66%532.85M-----30.35%2.05B----
Net cash from investment operations 101.27%12.85M201.89%1.18B402.02%416.01M-183.33%-3.59B-849.60%-1.01B342.82%391.03M-78.32%82.87M42.48%-1.27B122.31%135.4M-95.56%88.3M
Net cash before financing -22.24%-39.66B-24.32%-42.15B-10.62%-40.28B116.07%17.37B-6.40%-32.44B-22.48%-33.9B-5.66%-36.41B-10.17%8.04B-13.46%-30.49B-8.10%-27.68B
Cash flow from financing activities
New borrowing 7.23%97.25B13.87%62.01B27.18%37.09B12.97%89.16B5.51%90.69B9.94%54.45B-25.76%29.16B0.93%78.92B2.68%85.96B-6.35%49.53B
Refund 1.10%-69.57B-6.61%-34.94B-50.20%-21.43B-4.74%-84.7B5.32%-70.34B11.24%-32.77B51.34%-14.27B-22.85%-80.87B-29.52%-74.3B-7.10%-36.92B
Issuance of bonds ----7.94%6.8B-----17.67%17.29B-----56.54%6.3B-----21.28%21B-----6.58%14.49B
Interest paid - financing ----23.17%-1.42B-----4.43%-4.78B----5.75%-1.85B----1.48%-4.58B----11.06%-1.96B
Dividends paid - financing -12.67%-7.52B-39.57%-1.13B-14.36%-1.17B-3.94%-4.01B-3.04%-6.67B22.20%-809.18M1.91%-1.02B-5.51%-3.86B-5.81%-6.48B-7.62%-1.04B
Absorb investment income -48.51%94.42M-76.43%34.6M-78.49%13.9M-57.14%217.81M-56.51%183.36M-38.69%146.78M-40.86%64.63M-28.85%508.15M-89.78%421.64M17.44%239.39M
Issuance expenses and redemption of securities expenses -----350.00%-9B----28.68%-17B----82.67%-2B----23.12%-23.84B-----44.25%-11.54B
Other items of the financing business -166.71%-2.57B-10.54%-1.06B14.14%6.61B5.73%-1.87B922.68%3.85B-1.83%-956.08M34.05%5.79B0.24%-1.98B90.49%-468.39M-19.03%-938.9M
Adjustment item of financing business -----------------------------------0.01----
Net cash from financing operations -0.16%17.69B-5.41%21.3B7.03%21.11B61.25%-5.69B244.48%17.71B89.82%22.51B47.85%19.72B-825.27%-14.69B-73.54%5.14B-53.92%11.86B
Effect of rate -67.16%9.25M0.76%5.46M-269.17%-5.1M277.81%11.51M1,140.96%28.17M393.98%5.42M-200.95%-1.38M-64.54%3.05M-106.21%-2.71M133.61%1.1M
Net Cash -49.40%-21.96B-83.07%-20.85B-14.89%-19.17B275.60%11.68B42.02%-14.7B28.01%-11.39B20.99%-16.69B-160.59%-6.65B-242.97%-25.35B-11,847.56%-15.82B
Begining period cash 26.86%55.22B26.86%55.22B27.68%55.7B-13.25%43.53B-13.25%43.53B-13.25%43.53B-13.24%43.62B28.03%50.18B28.03%50.18B28.03%50.18B
Cash at the end 15.37%33.26B6.94%34.38B35.61%36.53B26.86%55.22B16.12%28.83B-6.44%32.15B-7.64%26.94B-13.25%43.53B-21.93%24.83B-12.62%34.36B
Cash balance analysis
Cash and cash equivalent balance --0--0--0--0--0--0--0--0--0--0
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)HKASCAS (2007)HKASCAS (2007)HKASCAS (2007)HKASCAS (2007)HKAS
Audit Opinions ------Unqualified Opinion------Unqualified Opinion----
Auditor ------Ernst & Young Huaming (Special General Partnership), Ernst & Young------Ernst & Young Huaming (Special General Partnership), Ernst & Young----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg